MetLife, Inc. (LON: 0K0X)
London
· Delayed Price · Currency is GBP · Price in USD
81.47
+0.86 (1.07%)
Dec 23, 2024, 6:32 PM BST
MetLife Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 30, 2021 | Dec '20 Dec 30, 2020 | Dec '19 Dec 30, 2019 | 2018 - 2014 |
Premiums & Annuity Revenue | 49,112 | 49,435 | 53,735 | 46,396 | 47,637 | 47,838 | Upgrade
|
Total Interest & Dividend Income | 20,827 | 19,858 | 15,852 | 21,326 | 16,048 | 17,959 | Upgrade
|
Gain (Loss) on Sale of Investments | -1,031 | -2,727 | -1,065 | 1,596 | -115 | 469 | Upgrade
|
Other Revenue | 2,436 | 335 | 242 | -630 | 4,272 | 3,354 | Upgrade
|
Total Revenue | 71,344 | 66,901 | 68,764 | 68,688 | 67,842 | 69,620 | Upgrade
|
Revenue Growth (YoY) | 12.39% | -2.71% | 0.11% | 1.25% | -2.55% | 2.47% | Upgrade
|
Policy Benefits | 53,104 | 53,027 | 54,221 | 49,397 | 47,765 | 49,136 | Upgrade
|
Other Operating Expenses | 11,929 | 11,667 | 10,922 | 11,100 | 12,239 | 12,628 | Upgrade
|
Total Operating Expenses | 65,033 | 64,694 | 65,143 | 60,497 | 60,004 | 61,764 | Upgrade
|
Operating Income | 6,311 | 2,207 | 3,621 | 8,191 | 7,838 | 7,856 | Upgrade
|
Interest Expense | -1,047 | -1,045 | -938 | -920 | -913 | -955 | Upgrade
|
Currency Exchange Gain (Loss) | 4 | 6 | 7 | 10 | 2 | 2 | Upgrade
|
Other Non Operating Income (Expenses) | -86 | 994 | 3,674 | 1,237 | - | - | Upgrade
|
EBT Excluding Unusual Items | 5,182 | 2,162 | 6,364 | 8,518 | 6,927 | 6,903 | Upgrade
|
Merger & Restructuring Charges | - | - | - | - | - | -108 | Upgrade
|
Pretax Income | 5,182 | 2,162 | 6,364 | 8,518 | 6,927 | 6,795 | Upgrade
|
Income Tax Expense | 1,399 | 560 | 1,062 | 1,642 | 1,509 | 886 | Upgrade
|
Earnings From Continuing Ops. | 3,783 | 1,602 | 5,302 | 6,876 | 5,418 | 5,909 | Upgrade
|
Net Income to Company | 3,783 | 1,602 | 5,302 | 6,876 | 5,418 | 5,909 | Upgrade
|
Minority Interest in Earnings | -21 | -24 | -18 | -21 | -11 | -10 | Upgrade
|
Net Income | 3,762 | 1,578 | 5,284 | 6,855 | 5,407 | 5,899 | Upgrade
|
Preferred Dividends & Other Adjustments | 201 | 198 | 185 | 201 | 216 | 178 | Upgrade
|
Net Income to Common | 3,561 | 1,380 | 5,099 | 6,654 | 5,191 | 5,721 | Upgrade
|
Net Income Growth | 47.59% | -70.14% | -22.92% | 26.78% | -8.34% | 15.15% | Upgrade
|
Shares Outstanding (Basic) | 718 | 758 | 803 | 863 | 908 | 938 | Upgrade
|
Shares Outstanding (Diluted) | 722 | 762 | 809 | 869 | 913 | 944 | Upgrade
|
Shares Change (YoY) | -6.67% | -5.76% | -6.96% | -4.80% | -3.30% | -6.85% | Upgrade
|
EPS (Basic) | 4.96 | 1.82 | 6.35 | 7.71 | 5.72 | 6.10 | Upgrade
|
EPS (Diluted) | 4.92 | 1.81 | 6.30 | 7.65 | 5.68 | 6.06 | Upgrade
|
EPS Growth | 61.66% | -71.27% | -17.65% | 34.68% | -6.27% | 23.42% | Upgrade
|
Free Cash Flow | 15,169 | 13,721 | 13,044 | 12,347 | 11,639 | 13,786 | Upgrade
|
Free Cash Flow Per Share | 21.00 | 18.00 | 16.13 | 14.20 | 12.75 | 14.60 | Upgrade
|
Dividend Per Share | 2.130 | 2.060 | 1.980 | 1.900 | 1.820 | 1.740 | Upgrade
|
Dividend Growth | 4.41% | 4.04% | 4.21% | 4.40% | 4.60% | 4.82% | Upgrade
|
Operating Margin | 8.85% | 3.30% | 5.27% | 11.92% | 11.55% | 11.28% | Upgrade
|
Profit Margin | 4.99% | 2.06% | 7.42% | 9.69% | 7.65% | 8.22% | Upgrade
|
Free Cash Flow Margin | 21.26% | 20.51% | 18.97% | 17.98% | 17.16% | 19.80% | Upgrade
|
EBITDA | 7,036 | 2,925 | 4,294 | 8,885 | 8,250 | 8,224 | Upgrade
|
EBITDA Margin | 9.86% | 4.37% | 6.24% | 12.94% | 12.16% | 11.81% | Upgrade
|
D&A For EBITDA | 725 | 718 | 673 | 694 | 412 | 368 | Upgrade
|
EBIT | 6,311 | 2,207 | 3,621 | 8,191 | 7,838 | 7,856 | Upgrade
|
EBIT Margin | 8.85% | 3.30% | 5.27% | 11.92% | 11.55% | 11.28% | Upgrade
|
Effective Tax Rate | 27.00% | 25.90% | 16.69% | 19.28% | 21.78% | 13.04% | Upgrade
|
Revenue as Reported | 71,348 | 66,905 | 68,770 | 68,696 | 67,842 | 69,620 | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.